 | Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 5.9%
americanbankingnews.com - March 5 at 7:52 PM |
| Gary W. Pace Acquires 1,500 Shares of Cardiff Oncology, Inc. (NASDAQ:CRDF) Stock
americanbankingnews.com - March 4 at 9:56 PM |
| Cardiff Oncology (NASDAQ:CRDF) Trading Down 8.9%
americanbankingnews.com - March 3 at 8:46 PM |
 | Cardiff Oncology to Present at H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 3 at 8:45 AM |
| Could The Cardiff Oncology, Inc. (NASDAQ:CRDF) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - February 27 at 9:52 AM |
| Cardiff Oncology (NASDAQ:CRDF) Stock Price Up 6.1%
americanbankingnews.com - February 26 at 7:19 PM |
| Cardiff Oncology (NASDAQ:CRDF) Announces Earnings Results, Misses Expectations By $0.05 EPS
americanbankingnews.com - February 26 at 1:46 PM |
| Cardiff Oncology Announces Fourth Quarter and Full Year 2020 Results and Recent Highlights
finance.yahoo.com - February 25 at 7:40 PM |
| Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 5.2%
americanbankingnews.com - February 25 at 7:16 PM |
| Cardiff Oncology to Participate in Gastrointestinal (GI) Oncology and Pancreatic Cancer Panel Discussion at the Cowen 41st Annual Health Care Conference
finance.yahoo.com - February 24 at 12:48 PM |
|
| Head to Head Analysis: Cardiff Oncology (NASDAQ:CRDF) & Mosaic ImmunoEngineering (OTCMKTS:CPMV)
americanbankingnews.com - February 21 at 2:18 AM |
| Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.1%
americanbankingnews.com - February 18 at 8:34 PM |
 | Cardiff Oncology (CRDF) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
msn.com - February 18 at 1:36 PM |
| Cardiff Oncology to Present at the LifeSci Partners Precision Oncology Day
finance.yahoo.com - February 16 at 2:52 PM |
| Cardiff Oncology (NASDAQ:CRDF) Stock Price Down 8.5%
americanbankingnews.com - February 12 at 8:18 PM |
| Cardiff Oncology (NASDAQ:CRDF) Trading 9.5% Higher
americanbankingnews.com - February 11 at 7:52 PM |
| Cardiff Oncology Presents Phase 2 mCRPC Trial Data Showing a Two-Fold Increase in Efficacy with an Optimized Onvansertib Dosing Schedule
finance.yahoo.com - February 11 at 12:37 PM |
| Why Cardiff Oncology Ran Up 1,350% in 2020
msn.com - January 31 at 9:21 AM |
| Why Cardiff Oncology Stock Is Crashing Today
msn.com - January 15 at 12:47 PM |
| Cardiff Oncology Presents Data that Continues to Demonstrate the Clinical Benefit of Onvansertib in KRAS-Mutated mCRC and Initial Findings from its Expanded Access Program
finance.yahoo.com - January 15 at 12:47 PM |
 | Okyo Pharma Li. Regulatory News
lse.co.uk - January 8 at 3:36 AM |
| Labcorp Awarded CDC Contract to Study Variants of COVID-19 Virus and Improve Public Health Response
finance.yahoo.com - January 7 at 5:34 PM |
| Hudson Technologies Applauds Adoption of Omnibus/Covid-19 Relief Which Includes the Phasedown of HFC Production
finance.yahoo.com - December 29 at 9:09 AM |
| Cardiff Oncology Announces the Appointment of Dr. Rodney Markin as Chairman of the Board
finance.yahoo.com - December 21 at 5:33 PM |
| Walgreens and Labcorp Make Pixel by Labcorp™ At-Home COVID-19 Collection Kit Available Through Walgreens Find Care®
finance.yahoo.com - December 21 at 7:23 AM |
| Hedge Funds Have Never Been This Bullish On Cardiff Oncology (CRDF)
finance.yahoo.com - December 16 at 3:22 PM |
| LabCorp receives FDA authorization for at-home COVID-19 kits
finance.yahoo.com - December 11 at 5:53 PM |
| LabCorp Receives FDA Authorization to Make At-Home COVID-19 Collection Kits Available Through Retail
finance.yahoo.com - December 9 at 6:19 PM |
| Cardiff Oncology Presents Data at ASH Demonstrating the Safety and Anti-Leukemic Activity of Onvansertib in Patients with Relapsed/Refractory AML
finance.yahoo.com - December 6 at 8:41 AM |
 | Cardiff Oncology: A Breakout Darkhorse In The Booming K-Ras Market
seekingalpha.com - November 24 at 10:07 AM |
|
| Cardiff Oncology to Participate in Fireside Chat at the Piper Sandler 32nd Annual Healthcare Conference
finance.yahoo.com - November 23 at 9:49 AM |
| Cardiff Oncology EPS in-line, beats on revenue
seekingalpha.com - November 5 at 8:08 PM |
| Cardiff Oncology Announces Third Quarter 2020 Results and Highlights
finance.yahoo.com - November 5 at 8:08 PM |
| Cardiff Oncology: A Solid Oncology Company With 50% Upside Potential
seekingalpha.com - November 3 at 2:45 PM |
| Have Insiders Been Buying Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares?
finance.yahoo.com - October 25 at 12:30 PM |
 | Why Cardiff Oncology's Stock Is Trading Higher Today
benzinga.com - October 22 at 2:12 PM |
| Hudson Technologies to Host Conference Call to Discuss Third Quarter 2020 Results
finance.yahoo.com - October 22 at 9:11 AM |
| Cardiff Oncology's onvansertib may overcome Zytiga resistance in prostate cancer
seekingalpha.com - October 20 at 1:59 PM |
 | Cardiff Oncology Inc.
barrons.com - October 17 at 10:55 PM |
| Cardiff Oncology's Onvansertib Could Possibly End Up Being A Solid Cancer Drug
seekingalpha.com - October 12 at 3:57 PM |
 | Why Cardiff Oncology Stock Skyrocketed Today
fool.com - October 8 at 5:21 PM |
 | Cardiff Oncology Rakes In Over 200% Gain In 3 Months
nasdaq.com - October 2 at 7:58 AM |
 | Thinking about trading options or stock in Alibaba, Cardiff Oncology, Penn National Gaming, Facebook, or Target?
marketwatch.com - September 30 at 12:27 PM |
| Cardiff Oncology prices equity offering at $13.50
seekingalpha.com - September 30 at 7:17 AM |
| Cardiff Oncology readies equity offering
seekingalpha.com - September 29 at 5:47 PM |
| Cardiff Oncology +1% on KOL event on September 23
seekingalpha.com - September 17 at 11:15 PM |
| Insider Buys Cardiff Oncology's Shares
finance.yahoo.com - September 17 at 11:15 PM |
| Cardiff Oncology's onvansertib shows sustained clinical benefit in colorectal cancer
seekingalpha.com - September 17 at 11:15 PM |
| Cardiff Oncology Presents Data at ESMO Confirming Efficacy of Onvansertib and Durability of Response in KRAS-Mutated Metastatic Colorectal Cancer (mCRC)
finance.yahoo.com - September 17 at 8:13 AM |
| Cardiff Oncology to Present Data Further Demonstrating the Safety and Efficacy of Onvansertib in KRAS-Mutated Metastatic Colorectal Cancer Patients
finance.yahoo.com - September 14 at 9:25 AM |
